SUSAN CURTIS: Open Payments
NPI 1831118728 · SHELBY TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 16 payments from 10 companies in 2025. Trend: 2023 $94 · 2024 $304 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Abbott Laboratories | 3 | $64 |
| Novo Nordisk Inc | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: CAPLYTA, FREESTYLE LIBRE 3, REXULTI, UBRELVY, Wegovy, VOQUEZNA, XIFAXAN, Rybelsus.
Industry payments across MI — which companies pay providers there.
